共 10 条
[6]
Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement[J] . I.Novak,L.Campbell,M.Boyce,V. S. C.Fung.European Journal of Neurology . 2010
[7]
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J] . D M. Simpson,A Blitzer,A Brashear,C Comella,R Dubinsky,M Hallett,J Jankovic,B Karp,C L. Ludlow,J M. Miyasaki,M Naumann,Y So.Neurology . 2008 (19,)
[8]
Efficacy and safety of a standardised 500 unit dose of Dysport? (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study[J] . J. Wissel,P. Kanovsky,E. Ruzicka,M. Bares,H. Hortova,H. Streitova,R. Jech,J. Roth,C. Brenneis,J. Müller,P. Schnider,E. Auff,A. Richardson,W. Poewe.Journal of Neurology . 2001 (12)
[9]
Cervical dystonia: Clinical findings and associated movement disorders[J] . Joseph Jankovic,Stuart Leder,Dhyanne Warner,Kenneth Schwartz.Neurology . 1991 (7)
[10]
Botulinum toxin type A in the treatment of patients withcervical dystonia .2 Allison B. Biologics:Targets&Therapy . 2009